Previous close | 25.46 |
Open | 25.50 |
Bid | 25.24 x 1200 |
Ask | 25.22 x 900 |
Day's range | 24.98 - 25.50 |
52-week range | 16.63 - 26.16 |
Volume | |
Avg. volume | 5,263,014 |
Market cap | 17.292B |
Beta (5Y monthly) | 1.37 |
PE ratio (TTM) | 53.51 |
EPS (TTM) | 0.47 |
Earnings date | 26 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 27.09 |
Avantor (AVTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ELV vs. AVTR: Which Stock Is the Better Value Option?
Growing patient volumes, advancements in technology, admissions, premium rate hikes and other factors are likely to have benefited healthcare players during Q1. Companies like CI, HCA, AVTR and THC can outperform.